Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …

The aim of the present study is to compare brain atrophy with hypometabolism as preclinical
markers of Alzheimer's disease (AD) by studying presymptomatic individuals from families …

Background Neurofilament light chain (NfL) is a promising blood biomarker in genetic
frontotemporal dementia, with elevated concentrations in symptomatic carriers of mutations in GRN…

Deciphering the genetic landscape of Alzheimer’s disease (AD) is essential to define the
pathophysiological pathways involved and to successfully translate genomics to potential …

The aim of this study was to evaluate the accuracy of neuropsychological assessment in
predicting conversion from subjective cognitive decline (SCD) and mild cognitive impairment (…

In patients with suspected dementia with Lewy bodies, the detection of the disease-associated
α-synuclein in easily accessible tissues amenable to be collected using minimally …

Importance Behavioral disturbances are core features of frontotemporal dementia (FTD);
however, symptom progression across the course of disease is not well characterized in …

We assessed the geographical distribution of C9orf72 G 4 C 2 expansions in a pan‐ E
uropean frontotemporal lobar degeneration ( FTLD ) cohort (n = 1,205), ascertained by the E …

Introduction Neurofilament light chain (NfL) is becoming increasingly notable in neurological
diseases including AD, and it has been suggested as a new peripherical biomarker of …

Background A hexanucleotide repeat expansion in the first intron of C9ORF72 has been
shown to be responsible for a high number of familial cases of amyotrophic lateral sclerosis or …